Bolt Biotherapeutics annual meeting elects directors and ratifies auditor

Bolt Biotherapeutics, Inc.

Director Kathleen LaPorte elected with 12,706,287 votes for, 3,990,176 withheld, 9,231,722 broker non-votes.
Director Nicole Onetto elected with 12,819,050 votes for, 3,880,294 withheld, 9,228,841 broker non-votes.
Ratification of PricewaterhouseCoopers LLP as auditor for FY2024: 23,736,566 for, 2,032,686 against, 158,933 abstaining.
Total shares represented at meeting: 25,928,185 of 38,127,740 shares entitled.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.